|
1.Sorokin, I.; Mamoulakis, C.; Miyazawa, K.; Rodgers, A.; Talati, J.; Lotan, Y., Epidemiology of stone disease across the world. World J Urol 2017, 35, (9), 1301-1320. 2.Wu, S. Y.; Shen, J. L.; Man, K. M.; Lee, Y. J.; Chen, H. Y.; Chen, Y. H.; Tsai, K. S.; Tsai, F. J.; Lin, W. Y.; Chen, W. C., An emerging translational model to screen potential medicinal plants for nephrolithiasis, an independent risk factor for chronic kidney disease. Evid Based Complement Alternat Med 2014, 2014, 972958. 3.Li, M.; Wang, W.; Xue, J.; Gu, Y.; Lin, S., Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol 2011, 133, (2), 412-9. 4.Litbarg, N. O., Integrative Medicine. Elsevier: New Mexico, 2017; p 411. 5.Kasper D, F. A., Hauser S, Longo D, Jameson J, Loscalzo J(Eds.), Harrison''s Principles of Internal Medicine, Nineteenth Edition 2015. 6.Ho, C. Y.; Chen, Y. H.; Wu, P. Y.; Chang, C. H.; Chen, H. Y.; Man, K. M.; Shen, J. L.; Tsai, F. J.; Lin, W. Y.; Lee, Y. J.; Chen, W. C., Effects of commercial citrate-containing juices on urolithiasis in a Drosophila model. Kaohsiung J Med Sci 2013, 29, (9), 488-93. 7.Chen, Y. H.; Liu, H. P.; Chen, H. Y.; Tsai, F. J.; Chang, C. H.; Lee, Y. J.; Lin, W. Y.; Chen, W. C., Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis. Kidney Int 2011, 80, (4), 369-77. 8.Wu SY, S. J., Man KM, Lee YJ, Chen HY, Chen YH, Tsai KS, Tsai FJ, Lin WY, Chen WC, An emerging translational model to screen potential medicinal plants for nephrolithiasis, an independent risk factor for chronic kidney disease. Evid Based Complement Alternat Med 2014, 2014:972958. 9.Knauf, F.; Preisig, P. A., Drosophila: a fruitful model for calcium oxalate nephrolithiasis? Kidney Int 2011, 80, (4), 327-9. 10.Juan, Y. C.; Kuo, Y. H.; Chang, C. C.; Zhang, L. J.; Lin, Y. Y.; Hsu, C. Y.; Liu, H. K., Administration of a decoction of sucrose- and polysaccharide-rich radix astragali (huang qi) ameliorated insulin resistance and Fatty liver but affected Beta-cell function in type 2 diabetic rats. Evid Based Complement Alternat Med 2011, 2011, 349807. 11.Zhang, J.; Xie, X.; Li, C.; Fu, P., Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J Ethnopharmacol 2009, 126, (2), 189-96. 12.Wu, C. Y.; Ke, Y.; Zeng, Y. F.; Zhang, Y. W.; Yu, H. J., Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells. Cancer Cell Int 2017, 17, 115. 13.Liu, P.; Zhao, H.; Luo, Y., Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic. Aging Dis 2017, 8, (6), 868-886. 14.Zhao, K. S.; Mancini, C.; Doria, G., Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology 1990, 20, (3), 225-33. 15.Du, X.; Chen, X.; Zhao, B.; Lv, Y.; Zhang, H.; Liu, H.; Chen, Z.; Chen, Y.; Zeng, X., Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells. FEMS Immunol Med Microbiol 2011, 63, (2), 228-35. 16.Auyeung, K. K.; Woo, P. K.; Law, P. C.; Ko, J. K., Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol 2012, 141, (2), 635-41. 17.Cho, W. C.; Leung, K. N., In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007, 252, (1), 43-54. 18.Chen, W. C.; Lin, W. Y.; Chen, H. Y.; Chang, C. H.; Tsai, F. J.; Man, K. M.; Shen, J. L.; Chen, Y. H., Melamine-induced urolithiasis in a Drosophila model. J Agric Food Chem 2012, 60, (10), 2753-7. 19.Chen, Y. H.; Lin, Y. N.; Chen, W. C.; Hsieh, W. T.; Chen, H. Y., Treatment of stress urinary incontinence by ginsenoside Rh2. Am J Chin Med 2014, 42, (4), 817-31. 20.Tsai, K.-S.; Chen, Y.-H.; Shen, J.-L.; Man, K.-M.; Wu, S.-Y.; Chen, H.-Y.; Chang, C.-H.; Lee, Y.-J.; Hsu, T.-F.; Tsai, F.-J.; Lin, W.-Y.; Chen, W.-C., Does Chronic Cola Consumption Increase Urinary Stone Risk? Evidence from the Drosophila Model of Urolithiasis. Journal of Food and Nutrition Research 2015, 3, 109-113. 21.Hirata, T.; Cabrero, P.; Berkholz, D. S.; Bondeson, D. P.; Ritman, E. L.; Thompson, J. R.; Dow, J. A.; Romero, M. F., In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol 2012, 303, (11), F1555-62. 22.Bellen, H. J.; Yamamoto, S., Morgan''s legacy: fruit flies and the functional annotation of conserved genes. Cell 2015, 163, (1), 12-4. 23.Bellen, H. J.; Tong, C.; Tsuda, H., 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci 2010, 11, (7), 514-22. 24.Venken, K. J.; Simpson, J. H.; Bellen, H. J., Genetic manipulation of genes and cells in the nervous system of the fruit fly. Neuron 2011, 72, (2), 202-30. 25.Pandey, U. B.; Nichols, C. D., Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 2011, 63, (2), 411-36. 26.Landry, G. M.; Hirata, T.; Anderson, J. B.; Cabrero, P.; Gallo, C. J.; Dow, J. A.; Romero, M. F., Sulfate and thiosulfate inhibit oxalate transport via a dPrestin (Slc26a6)-dependent mechanism in an insect model of calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol 2016, 310, (2), F152-9. 27.Fan, Q.; Feng, X.; Hong, X.; Gong, S.; Tian, J.; Hou, F.; Zhang, F., Garcinia cambogia extract removes calcium oxalate kidney stones in both genetic and non-genetic Drosophila models of nephrolithiasis. bioRxiv 2018, 477570. 28.Lin, W. C.; Lai, M. T.; Chen, H. Y.; Ho, C. Y.; Man, K. M.; Shen, J. L.; Lee, Y. J.; Tsai, F. J.; Chen, Y. H.; Chen, W. C., Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats. Urol Res 2012, 40, (6), 655-61. 29.Chen, W. C.; Wu, S. Y.; Liao, P. C.; Chou, T. Y.; Chen, H. Y.; Chiang, J. H.; Su, Y. C.; Man, K. M.; Tsai, M. Y.; Chen, Y. H., Treatment of Urolithiasis with Medicinal Plant Salvia miltiorrhiza: A Nationwide Cohort Study. Evid Based Complement Alternat Med 2018, 2018, 8403648. 30.Chen, W. C.; Chou, T. Y.; Chen, H. Y.; Yang, Y. R.; Man, K. M.; Tsai, M. Y.; Chen, Y. H., Salvia miltiorrhiza Bunge (Danshen) for Treatment and Prevention of Urolithiasis: A Drosophila Animal Study. Evid Based Complement Alternat Med 2019, 2019, 1408979. 31.Lin, L.-H.; Chiang, J.-H.; Chi Chou, P.-.; Liao, P.-C.; Wu, S.-Y.; Tsai, K.-S.; Chen, H.-Y.; Chen, Y.-H.; Chen, W.-C., Chinese Herbal Medicine Safflower (Flos carthami) Does Not Increase Bleeding Complications: A Population-based Cohort Study. Journal of Food and Nutrition Research 2016, 4, (2), 108-114. 32.Chen, W. C.; Chen, H. Y.; Liao, P. C.; Wang, S. J.; Tsai, M. Y.; Chen, Y. H.; Lin, W. Y., Toward a new insight of calcium oxalate stones in Drosophila by micro-computerized tomography. Urolithiasis 2018, 46, (2), 149-155. 33.Chung, J.; Granja, I.; Taylor, M. G.; Mpourmpakis, G.; Asplin, J. R.; Rimer, J. D., Molecular modifiers reveal a mechanism of pathological crystal growth inhibition. Nature 2016, 536, (7617), 446-50. 34.Chen WC, C. H., Lin WY, Yang YR, Tsai MY, Chen YH, Inhibitory Effect of Hydroxycitrate on Calcium Oxalate Crystal Formation in a Drosophila Model. Journal of Food and Nutrition Research 2018, 6, 706-9. 35.Chen WC, W. Y., Shen JL, Chen HY, Chang CH, Tsai FJ, Lin WY, Chen YH, Potential genitourinary toxicity and lithogenic effect of ractopamine. Journal of Food and Nutrition Research 2015, 3 670-4. 36.Miller, J.; Chi, T.; Kapahi, P.; Kahn, A. J.; Kim, M. S.; Hirata, T.; Romero, M. F.; Dow, J. A.; Stoller, M. L., Drosophila melanogaster as an emerging translational model of human nephrolithiasis. J Urol 2013, 190, (5), 1648-56. 37.https://en.wikipedia.org/wiki/Ethylene_glycol 38.U.S. Department of Health and Human Services, A. f. T. S. a. D. R. D. o. T. a. E. M., Environmental Medicine and Educational Services Branch. 39.Jacobsen, D.; McMartin, K. E., Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986, 1, (5), 309-34. 40.Lee YH, C. L., Chen MT et al, Characterization of ethylene glycol induced urolithiasis model in rats. J Urol ROC 1991, 2, 518-513. 41.Lee YH, H. W., Huang JK, Chang LS, Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 1996, 156(2 Pt 1), 502-5. 42.Huang, H. S.; Chen, C. F.; Chien, C. T.; Chen, J., Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 2000, 85, (9), 1143-9. 43.Tsai, C. H.; Chen, Y. C.; Chen, L. D.; Pan, T. C.; Ho, C. Y.; Lai, M. T.; Tsai, F. J.; Chen, W. C., A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats. Urol Res 2008, 36, (1), 17-24. 44.Tsai, C. H.; Pan, T. C.; Lai, M. T.; Lee, S. C.; Chen, M. L.; Jheng, J. R.; Chen, W. C., Prophylaxis of experimentally induced calcium oxalate nephrolithiasis in rats by Zhulingtang, a traditional Chinese herbal formula. Urol Int 2009, 82, (4), 464-71. 45.Chen WC, L. H., W HC, Tsai CH, Chen HY, Chen HY, Tsai FJ, Chang CH, Liu PL, Lin FY, Chang YC, Lin WY, Chen YH, Preliminary study of ethylene glycol-induced alanine-glyoxylate aminotransferase 2 expression in rat kidney. Current Urology 2009, 3, 129-35. 46.Chung, V. Y.; Turney, B. W., A Drosophila genetic model of nephrolithiasis: transcriptional changes in response to diet induced stone formation. BMC Urol 2017, 17, (1), 109. 47.Cohen, E.; Sawyer, J. K.; Peterson, N. G.; Dow, J. A. T.; Fox, D. T., Physiology, Development, and Disease Modeling in the Drosophila Excretory System. Genetics 2020, 214, (2), 235-264.
|